Invesco EQQQ Nasdaq100 UCITS ETF (EQQU.GB) Cotización

lol...I can only imagine anyone who bet the farm, or even 1/4 of the farm.....yikes !

I'm not sure how to ask this question or even if I should. In a discussion the other day the question was asked, knowing the recent actions/failures of the SS and FBI, if yet to be President Trump was, heaven forbid, assassinated tomorrow just as he is taking oath of office, would he still be consid

A Bob Lutz type.  But you will never get a top tier  leader to move to Latham or take on this Mess.

https://resources.arcamax.com/newspics/cache/lw600/322/32234/3223444.jpg

For the uneducated like thommas and shita2000 ............

"Under provisions of the 20th Amendment, the terms of President Joe Biden and Vice President Kamala Harris will officially end at 11 a.m. CT on Jan. 20, meaning that Trump and Vice President-elect J.D. Vance will officially ta

1st place bonus in the last 3 events is 400 points each for your Captain--it ain't over 'til it's over as Yogi would say

So now we know that Jensen Huang is a hypocrite.

https://assets.amuniversal.com/2b903b30a185013d8479005056a9545d

Much respect gained with that reply. I hope to follow your example when called for.

You are misrepresenting my post,
But that’s your schtick

First, a performance stock bonus is, just that, for performance.
Why wouldn’t you want someone to have performance incentives? Crazy chet going on here bashing that.

Second, in my post I am showing

the under looks solid, it's snowing here really hard, hope it moves East...

I took under 19 1/2 2nd half, appears to be another gift.....we'll see..lol..

take advantage...BUY THE DIP it wont last

bbotcs- GERN

I have a lot of knowledge about their drug Rytelo vs Bristol Myers Reblozyl. Both drugs are used to treat low risk Myelodysplasia syndrome(MDS), a deadly anemia. Also these two drugs are the only ones worldwide to treat low risk MDS effectively. Here is the main diffe

https://www.youtube.com/watch?v=CGoslFcm3c8 The Real Reason United Invested in Archer Instead of Joby!

Sab, I agree with "imho": CM did showcase the info to a new audience and the OLE data was always scheduled for the April academic conference (see Hosai's 12DEC post containing Grimmer abstract.)

There was never going to be massive news - but there was great news about 3-71 trial, in

Still hoping
This story ends like Jack and the bean stalk

"You keep digging your hole. Recall your foolishness about PDD. The Rett AUC. Rett approval. ADL "success". Just a few weeks ago, the JPM HCC time allotment.
At some point, you have to stop digging. Be an investor. It won't scare you."

What are you suggesting? He should short?

at 3% yield = $67

https://x.com/guidoperei/status/1881091438152474744?s=46&t=2Y42DPZFgRdwTBHj5W8jMQ

Did I hurt your feelings?? Lol!! I'm sorry!! I made plenty of money from Bcap!! Now I'm waiting for more!! Things don't always go as expected and a real investor knows that!! You Sir have been very unsuccessful and it shows!!

"Which drug is safer to you, mabs (inlcuding leqimbi) or our small molecule?

If both were approved, which one would you treat YOUR FAMILY member with at early stages of AD?"

If regulators value this question more than they value possible data imperfections in Blarcamisi

I really do not understand the nuances of the markets, but could it be that RSPI is heading towards a NASDAQ listing?

The trials were conducted by Anavex , peer review articles are expected to be written by persons intimately familiar with the trial, so by reason people working within that trial would have some relationship with Anavex pretty normal really , not a conflict of interest , that’s why they disclose

ok.....